Galapagos | GLPG - Interest Expense On Debt

Stock Price
28.40
Daily Change
-0.30 -1.05%
Monthly
-1.87%
Yearly
12.70%
Q1 Forecast
27.85

Galapagos reported EUR1.72M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
argenx SE USD 993K 133K Sep/2025
AstraZeneca USD 484M 181M Dec/2025
Biogen USD 72.6M 12.6M Jun/2025
Genmab DKK 37M 28M Sep/2025
Gilead Sciences USD 255M 1000K Dec/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 20M 2M Jun/2025
Incyte USD 582K 10K Dec/2025
Merck EUR 126M 47M Sep/2025
Neurocrine Biosciences USD 1.1M 0 Mar/2024
Novartis USD 281M 8M Sep/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025
UCB EUR 78M 30M Jun/2025
Vertex Pharmaceuticals USD 3.3M 0 Dec/2025